Ocuvir 5 Gm

Olopat 5 ml Eye Drops (Olopatadine Hydrochloride Ophthalmic Solution 0.1% w/v) is a high-efficacy, dual-action antihistamine and mast cell stabilizer manufactured by Ajanta Pharma Ltd. Specifically formulated for the rapid relief of symptoms associated with seasonal allergic conjunctivitis, Olopat provides a synergistic approach to managing ocular itching, redness, and swelling. Its clinical profile is defined by a rapid onset of action and a sustained therapeutic window, making it a cornerstone of modern allergy management.

1. Manufacturer Profile: Ajanta Pharma Ltd

Ajanta Pharma is a specialized Indian multinational with a strong global focus on ophthalmology, known for its innovative delivery platforms and high manufacturing standards.

• Quality Assurance: Produced in state-of-the-art facilities certified under WHO-GMP and inspected by international regulatory bodies, ensuring that every 5 ml bottle of Olopat meets global pharmacological benchmarks.
• Ophthalmic Focus: Ajanta’s specialized expertise in ocular surface diseases ensures that Olopat is formulated with optimal pH and isotonicity for maximum patient tolerability.

2. Composition & Active Ingredients

Each 1 ml of Olopat Eye Drops contains:

• Active Ingredient: Olopatadine Hydrochloride IP equivalent to Olopatadine 1 mg (0.1% w/v).
• Preservative: Benzalkonium Chloride 0.01% w/v (to ensure multi-dose sterility).
• Vehicle: Sterile aqueous solution designed to mimic the natural physiological environment of the eye.

3. Mechanism of Action: How It Works

Olopatadine, the active agent in Olopat, utilizes a two-pronged attack to neutralize the allergic response.

A. Selective H1 Receptor Antagonism

Upon application, the molecule rapidly binds to histamine H1 receptors on the ocular surface. By blocking these receptors, Olopat immediately halts the signal for itching and prevents the initial vascular leakage that leads to redness and swelling.

B. Mast Cell Stabilization

Unlike first-generation antihistamines, Olopat also stabilizes mast cells—the source of the allergic response. It prevents these cells from degranulating and releasing additional histamine, prostaglandins, and leukotrienes. This stabilizing effect provides long-term protection against the “late-phase” allergic reaction, typically lasting 8 to 12 hours.

4. Therapeutic Indications

Olopat 5 ml is clinically indicated for the following conditions:

• Seasonal Allergic Conjunctivitis: Rapidly relieving ocular itch and redness caused by pollen and outdoor allergens.
• Perennial Allergic Conjunctivitis: Managing chronic indoor allergies such as pet dander and dust mites.
• Ocular Hyperemia: Effectively reducing the “pink eye” appearance associated with allergic triggers.

5. Clinical Comparison: Olopat vs. Standard Antihistamines

6. Dosing & Administration

Standard Dosing Schedule

• Adults and Children (3+ Years): One drop in each affected eye twice daily (every 6 to 8 hours).

Application Instructions

1. Wash hands thoroughly.
2. Tilt the head back and pull down the lower eyelid to create a small pocket.
3. Hold the dropper above the eye and instill one drop. **Do NOT touch the dropper tip to the eye.**
4. Close the eye for 2 minutes and apply gentle pressure to the tear duct (inner corner).
5. Wait 15 minutes before re-inserting contact lenses.

7. Precautions & Safety Warnings

• Contact Lenses: Olopat contains Benzalkonium Chloride, which can be absorbed by soft contact lenses. Avoid wearing lenses while eyes are red or during the immediate application period.
• Contamination: Keep the bottle tightly closed. Discard any solution remaining 4 weeks after opening.
• Side Effects: Common localized effects include mild stinging, blurred vision, or dry eye sensation.

8. Well-Researched FAQs

Q: How fast does Olopat work?

A: Most patients feel a significant reduction in itching within 30 minutes of the first application, with maximum relief occurring within the first few hours.

Q: Can I use Olopat for more than 2 weeks?

A: While Olopat is safe for long-term seasonal use, you should consult your ophthalmologist if symptoms do not improve significantly within 72 hours.

Q: Is Olopat safe for children?

A: Yes, it is typically approved for pediatric use in children aged 3 years and older. Always follow the specific guidance of a pediatrician.

9. Official Regulatory References

1. Ajanta Pharma Ophthalmic Index: Official Product Portfolio
2. DailyMed NIH: Olopatadine Hydrochloride Ophthalmic Monographs.

Medical Disclaimer: This content is AI-generated for educational purposes based on clinical pharmaceutical data. It is NOT medical advice. Always consult a licensed healthcare professional for diagnosis and treatment.